Information
Last updated: 21 June 2024

Migraine

Information
Migraine

Overview

Migraines are severe, often bilateral, throbbing headaches commonly located in the temples or frontal regions of the head. They affect different age groups with varying prevalence rates: 2-5% in preschool children, 10% in school-aged children, and 20-30% in adolescent girls (Abu-Arafeh and Russell, 1994; Aromaa et al., 1998). Approximately 20% of migraine patients experience their first attack before the age of 5 (Bille, 1997).

Symptoms by Age Group

Preschool Children:

  • Symptoms: Episodes of ill appearance, pallor, abdominal pain, vomiting, and the need for sleep.
  • Behavior: Expressed through irritability, crying, rocking, or seeking a dark room to sleep.

Children Aged 5-10 Years:

  • Symptoms: Bilateral frontal, temporal, or retro-orbital headache, nausea, abdominal cramping, vomiting, photophobia, phonophobia, and a need to sleep.
  • Physical Appearance: Pale with dark circles under the eyes.

Older Children:

  • Symptoms: Unilateral, temporal headache with variable pain location and intensity within or between episodes.

Migraine with and without Aura

  • Aura Prevalence: 10-20% of children with migraines experience an aura, often after the age of 8.
  • Aura Characteristics: Precedes the headache by less than 60 minutes, lasts for 5-20 minutes, may occur without headache.
  • Types of Aura: Visual auras (blurred vision, fortification spectra, scotomata, scintillations, black dots, kaleidoscopic patterns, micropsia, macropsia, metamorphopsia), attention loss, confusion, amnesia, agitation, aphasia, ataxia, dizziness, vertigo, paresthesia, or hemiparesis.

Duration and Intensity

  • Headache Duration: Can last from 60 minutes to 48 hours, typically less than 4 hours. Some report short headaches lasting 10-20 minutes.
  • Severity: Generally milder than adult migraines.

Associated Symptoms

  • During Headache Phase: Cold extremities, nausea, anorexia, vomiting, diarrhea, constipation, dizziness, chills, excessive sweating, ataxia, numbness, photophobia, phonophobia, memory loss, confusion, difficulty concentrating.
  • Relief: Typically associated with sleep.
  • Post-Headache Phase: Feelings of elation and energy or exhaustion and lethargy, lasting from hours to days (Gladstein et al., 1993).

Comorbid Conditions

  • Psychiatric Symptoms: Depression, panic episodes, anxiety disorders, phobia.
  • Epilepsy: Co-occurrence with migraines, though most migraineurs do not have seizures.
  • Motion Sickness and Vertigo: More common in migraineurs.
  • Cardiovascular Reactivity: Higher reactivity to postural changes, leading to dizziness.
  • Other Associations: Sleep disturbances, ice-cream headaches (Raskin and Knittle, 1976; Kuritzky et al., 1981; Schoenen et al., 1998; Dodick et al., 2003; Maizels and Burchette, 2004; Pellock, 2004).

Types of Migraine

Status Migrainosus

Status migrainosus is a severe form of migraine characterized by a continuous headache attack lasting longer than 72 hours. Patients typically have a pre-existing history of migraines. For those who experience vomiting, rehydration is often the first step in treatment. Effective treatments may include intravenous fluids, antiemetics, and dihydroergotamine (DHE) (Linder, 1994).

Familial Hemiplegic Migraine

Familial hemiplegic migraine is an autosomal-dominant form of migraine with aura. Patients experience prolonged hemiplegia, which can be accompanied by numbness, aphasia, and confusion. Hemiplegia may precede, accompany, or follow the headache, with symptoms lasting from hours to days. The headache is usually contralateral to the hemiparesis. Some cases are associated with cerebellar ataxia, and severe forms may present with coma, fever, and meningismus. Treatment may include acetazolamide or calcium channel blockers. Differential diagnosis should consider structural lesions, vasculitis, cerebral hemorrhage, brain tumor, mitochondrial myopathy, encephalopathy, alternating hemiplegia, and lactic acidosis. Mutations in CACNA1A, ATP1A2, SCN1A, and PRRT2 genes are associated with this type of migraine (de Vries et al., 2007).

Basilar-Type Migraine

Basilar-type migraine, a subtype of migraine with aura, primarily affects adolescent and young adult females. Headache pain may be located in the occipital area. This type involves disturbances originating from the brainstem, occipital cortex, and cerebellum. Aura symptoms include dysarthria, vertigo, tinnitus, hyperacusis, diplopia, bi-field visual symptoms, ataxia, decreased level of consciousness, or bilateral paresthesias. Many patients have a family history of typical migraine (Brenner et al., 2007).

Benign Paroxysmal Vertigo of Childhood

Benign paroxysmal vertigo of childhood is characterized by brief episodes of vertigo, disequilibrium, and nausea, usually affecting children aged 2-6 years. Nystagmus may be present during episodes but not between them. There is no associated hearing loss, tinnitus, or loss of consciousness. Symptoms typically last a few minutes, and affected children often develop a more common form of migraine as they mature. MRI can be used to exclude posterior fossa abnormalities (Abu-Arafeh and Russell, 1995).

Acute Confusional Migraine

Acute confusional migraine involves transient episodes of amnesia, acute confusion, agitation, lethargy, and dysphasia. Often precipitated by minor head trauma, this form of migraine may present with receptive or expressive aphasia and a confusional state that precedes or follows the headache. Recovery usually occurs within hours. It is important to exclude other conditions such as hypoglycemia, intoxications, encephalitis, structural lesions, and seizures (Shaabat, 1996).

Migraine-Associated Cyclic Vomiting Syndrome

This syndrome is characterized by recurrent periods of intense vomiting separated by symptom-free intervals. Symptoms often include abdominal pain, nausea, retching, anorexia, pallor, lethargy, photophobia, phonophobia, and headache. The condition typically begins in toddlerhood and resolves by adolescence or early adulthood. These children often require intravenous fluid therapy due to severe fluid and electrolyte disturbances. A diagnosis of exclusion, other causes such as gastrointestinal, metabolic, endocrine, and mitochondrial disorders must be ruled out (Andersen et al., 1997; Rashed et al., 1999).

Abdominal Migraine

Abdominal migraine involves recurrent episodes of generalized abdominal pain with nausea and vomiting, often without headache. Episodes are relieved by sleep, with children feeling better upon waking. This condition may alternate with or evolve into typical migraines as the child matures. Treatment with migraine prophylactic medication is often effective (Dignan et al., 2001; Russell et al., 2002).

Paroxysmal Torticollis of Infancy

An uncommon disorder, paroxysmal torticollis of infancy features repeated episodes of head tilting accompanied by nausea, vomiting, and headache. Episodes usually occur in infants and last from minutes to days. Differential diagnosis should consider posterior fossa abnormalities. Some cases are linked to mutations in the CACNA1A gene (Abu-Arafeh and Russell, 1995; Drigo et al., 2000; Giffen et al., 2002).

Acephalgic Migraine

Acephalgic migraine, also known as migraine sine hemicrania, is characterized by a migraine aura without headache, typically involving visual auras and more commonly affecting females. A family history of migraine is frequent.

Migraine Aura and Retinal Migraine

Migraine aura occurs in about one-third of adult and adolescent patients, featuring symptoms such as blurred vision, fortification spectra, scotomata, scintillations, black dots, kaleidoscopic patterns, micropsia, macropsia, and metamorphopsia. Aura symptoms can include attention loss, confusion, amnesia, agitation, aphasia, ataxia, dizziness, vertigo, paresthesia, or hemiparesis. Retinal migraine is an uncommon condition involving repeated episodes of monocular visual disturbance associated with migraine headache (Lendvai et al., 1999).

Ophthalmoplegic Migraine

Ophthalmoplegic migraine is an inflammatory disorder characterized by ophthalmoplegia, typically a unilateral third nerve palsy, and headache. MRI studies during an attack may show inflammation of the third cranial nerve. Episodes may last for days and can be recurrent (Brenner et al., 2007).

Evaluation and Diagnosis of Migraine

Diagnostic Process

Diagnosing migraine relies on the patient's history, physical examination, and clinical judgment, as no specific diagnostic tests exist. A child with migraine should have a normal general physical examination and a detailed neurological examination. Only a small percentage of headache patients require further laboratory and radiologic studies.

When to Consider Imaging

Imaging studies should be considered in patients with:

  • History of seizures
  • Recent head trauma
  • Significant change in headache pattern
  • Evidence of focal neurological deficits
  • Papilledema upon physical examination

The decision to perform neuroimaging is based on clinical judgment. Electroencephalography (EEG) is generally not useful in the routine evaluation of headache patients but may be considered for atypical migraine aura, episodic loss of consciousness, or symptoms suggestive of a seizure disorder. Lumbar puncture is indicated if meningitis, encephalitis, subarachnoid hemorrhage, or high/low-pressure syndromes are considered. Patients with suspected elevated intracranial pressure or focal neurological deficits should undergo neuroimaging before a lumbar puncture (Lewis et al., 2002).

Treatment and Prognosis of Migraine

Treatment Strategies

Treatment of migraine headaches focuses on identifying environmental triggers, controlling pain during the headache, and preventive medication. For children with mild, infrequent episodes, treatment primarily involves rest, trigger avoidance, and analgesics.

Lifestyle and Education:

  • Maintain regular bedtime and meal schedules
  • Avoid overloading the child's schedule with activities
  • Help the child recognize migraine triggers

Psychological and Physiological Triggers:

  • Psychological: Stress, anxiety, worry, depression, bereavement (Anttila et al., 2004)
  • Physiological: Fever, illness, missing meals, fatigue, sleep deprivation

Environmental Triggers:

  • Fluorescent light, bright light, flickering light
  • Barometric pressure changes, high altitude, strong odors
  • Computer screens, rapid temperature changes
  • Complex visual patterns (stripes, checks, zigzag lines)
  • Physical exertion, minor head trauma, travel or motion (Jan, 1998)

Acute Management

During a headache, advise the child to lie down in a cool, dark, quiet room and try to sleep, as sleep is the most potent antimigraine treatment. Some patients find relief with ice or pressure on the affected area. Nonsteroidal anti-inflammatory agents are effective if taken at an appropriate dosage during the aura or early headache phase. Gastric stasis in migraine patients may delay the absorption of oral medications, and carbonated beverages can sometimes improve absorption. Nonpharmacological treatments such as self-relaxation, biofeedback, and self-hypnosis may be reasonable alternatives, especially in adolescents (Lewis, 2004).

Prophylactic Medications

Prophylactic or preventive medications are taken daily to reduce the frequency or severity of headaches and associated symptoms. A good response is often considered a 50% reduction in episode frequency or severity. Prophylactic drugs should be considered for children with frequent (>2 per week), prolonged, and disabling migraine episodes that do not respond to other treatments. It may take several weeks to observe therapeutic gains. Possible medications include:

  • Amitriptyline
  • Propranolol
  • Gabapentin
  • Valproate
  • Topiramate
  • Flunarizine
  • Verapamil
  • Riboflavin (Hershey et al., 2000; Silberstein et al., 2012)

Evidence and Effectiveness

High-quality evidence for the best preventive treatment of childhood migraine is limited. High placebo response rates in children (50-70%) complicate demonstrating the efficacy of single approaches. A recent randomized controlled trial found that placebo response rates approached 60%, with topiramate and amitriptyline failing to exceed this rate (Powers et al., 2017). However, the best available evidence supports the use of topiramate and cognitive behavioral therapy in treating migraine.

Long-Term Prognosis

Migraine frequency may change as children transition into adulthood. In a longitudinal study, children with migraine were followed for 40 years (Bille, 1997). Key findings include:

  • Average onset age: 6 years
  • 62% were migraine-free for at least 2 years during puberty or young adulthood
  • 33% regained regular episodes after an average of six migraine-free years
  • 60% still had migraines after 30 years
  • 22% never had a migraine-free year
  • 52% of those who became parents had at least one child with recurrent migrainous headaches

Related Articles

Migraine in childhood

Text is available under the Cc by nc sa iconCC Attribution-Noncommercial-Share Alike 4.0 International; additional terms may apply.